Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials
Yanlun Gu, Bingqi Dong, Xu He, et al.
Pharmacological Research (2023) Vol. 189, pp. 106694-106694
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
The role of the hypothalamic–pituitary–thyroid axis in thyroid cancer
Laura Abaandou, Raisa Ghosh, Joanna Kłubo-Gwieździńska
The Lancet Diabetes & Endocrinology (2025)
Closed Access | Times Cited: 1
Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin αvβ3
Kehuang Liu, Tao Jiang, Wanqian Rao, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 6, pp. 1544-1557
Closed Access | Times Cited: 7
A PTT-Induced Feed-Back Carbon Nanosystem for Enhanced Breast Cancer Therapy by Extracellular Matrix Remodeling
Min Zheng, Hua Zhang, Mingyuan Dai, et al.
Nano Letters (2025)
Closed Access
Interaction of integrin αvβ3 and fibronectin under fluid shear forces: implications for tumor cell adhesion and migration
Paimin Zhuo, Quhuan Li, Bishan Yang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Designing nanoparticles to minimize unintended inflammatory responses: a step toward safer and more effective precision nanomedicine
Yuan Feng, Zhong-Da Li, Qi Li, et al.
Nanomedicine (2025), pp. 1-5
Closed Access
Cell Progression and Survival Functions of Enzymes Secreted in Extracellular Vesicles Associated with Breast and Prostate Cancers
Cosmos Ifeanyi Onyiba, Namita Kumar, Christopher J. Scarlett, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 468-468
Open Access
On-site delivery of bioactive nanospheres utilizing lanthanides as crosslinkers and metastasis-inhibiting agents for breast cancer therapy
Yu‐Chi Wang, Yan-Ting Lin, P. S. Hsieh, et al.
Journal of Controlled Release (2025), pp. 113671-113671
Closed Access
Molecular basis of β2 integrin activation by talin unveils subunit-specific mechanisms of integrin signaling
Tong Gao, Nicholas A. Maskalenko, S. Kabir, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115607-115607
Closed Access
Roles for epithelial integrin α3β1 in regulation of the microenvironment during normal and pathological tissue remodeling
Rakshitha Pandulal Miskin, C. Michael DiPersio
AJP Cell Physiology (2024) Vol. 326, Iss. 5, pp. C1308-C1319
Closed Access | Times Cited: 3
Effective photothermal-photodynamic treatment of hepatocellular carcinoma based on polydopamine-coated mesoporous silica nanoparticles
Xin Su, Junjie Fu, Jing Hu, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 693, pp. 133931-133931
Closed Access | Times Cited: 2
Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis
Xiangwu Geng, Yifan Tang, Changjiang Gu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Metal nanozymes modulation of reactive oxygen species as promising strategies for cancer therapy
Jin-Wei Bu, Zhigang Wang, Haoyang Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124453-124453
Closed Access | Times Cited: 2
CC5 and CC8, Two Disintegrin Isoforms from Cerastes cerastes Snake Venom Decreased Inflammation Response In Vitro and In Vivo
Maram Morjen, Ons Zakraoui, Zaineb Abdelkafi-Koubaa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12427-12427
Open Access | Times Cited: 5
Small Molecules against Metastatic Tumors: Concrete Perspectives and Shattered Dreams
Massimo Serra, Davide Rubes, Sergio Schinelli, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4173-4173
Open Access | Times Cited: 5
Data-driven prediction of αβ3 integrin activation paths using manifold learning and deep generative modeling
Siva Dasetty, Tamara C. Bidone, Andrew L. Ferguson
Biophysical Journal (2023) Vol. 123, Iss. 17, pp. 2716-2729
Closed Access | Times Cited: 5
Determination of the binding affinities of OPEs to integrin αvβ3 and elucidation of the underlying mechanisms via a competitive binding assay, pharmacophore modeling, molecular docking and QSAR modeling
Ying Xu, Lei Yang, Jian Li, et al.
Journal of Hazardous Materials (2024) Vol. 466, pp. 133650-133650
Closed Access | Times Cited: 1
The potential of bacterial anti-phagocytic proteins in suppressing the clearance of extracellular vesicles mediated by host phagocytosis
Jiacong Sun, Congcong Chen, Pengpeng Pan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
New PET Tracers for Lymphoma
Johanna S. Enke, Ralph A. Bundschuh, Rainer Claus, et al.
PET Clinics (2024) Vol. 19, Iss. 4, pp. 463-474
Closed Access | Times Cited: 1
EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics
Cibele Rodrigues Toledo, Ahmed A. Tantawy, Leonardo Lima Fuscaldi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8553-8553
Open Access | Times Cited: 1
Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine–Glycine–Aspartate) Strategies
B. Bogdanovič, Daniel Fagret, Cathérine Ghezzi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1556-1556
Open Access | Times Cited: 1
Structural analysis of peptide binding to integrins for cancer detection and treatment
Mauricio Urquiza, Daniela Benavides-Rubio, Silvia Jimenez-Camacho
Biophysical Reviews (2023) Vol. 15, Iss. 4, pp. 699-708
Open Access | Times Cited: 3
Progress of engineered bacteria for tumour therapy
Xue Xia, Jingwen Zhang, Bing Zhao, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111935-111935
Closed Access
Structure of Talin Bound to β2 Integrin Unveils the Molecular Mechanism of Species-Specific Integrin Activation
Tong Gao, Nicholas A. Maskalenko, S. Kabir, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Effects of the Carrier and Ligand Spatial Conformation on RNA Nanodrug Cell Delivery
Zhuang Zhang, Siying Li, Hongda Wang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 32, pp. 13226-13233
Closed Access
Page 1 - Next Page

Scroll to top